Middle East & AfricaENPublic drug registration overview
Kuwait Pharmaceutical Registration Pathway
Market Overview Market profile: Kuwait is dominated by the public healthcare system and import channels. GCC and referencemarket approvals from SFDA/EMA/FDA often have practical va...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in or register to view the complete pharmaceutical country report.
AI Citation Summary
- Country: Kuwait Pharmaceutical Registration Pathway
- Product line: Pharmaceuticals
- Regulator / source: Regulatory maturity: Medium. MOH pharmaceutical affairs and drug control functions manage registration and import permits.
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: Regulators typically question safety, efficacy, quality, GMP, BE/clinical evidence, labeling, and risk management. Project plans should reserve at least one deficiency-response cycle and should not treat official target timelines as guaranteed launch dates.
- Key fees: Marketing authorisation for medicines in Kuwait is generally managed by Kuwait Ministry of Health (MOH). For a foreign company, the project is not only a technical dossier submission. It also requires a local applicant or holder, importer or representative, manufacturing-site GMP evidence, labeling, post-market safety responsibility, and future variation control. The official entry point should be checked through https://www.moh.gov.kw before project launch for current forms, systems, fees, and guidance.
- Local requirement: Core decision: Confirm local agent, import permit, GCC/reference-market evidence, and Arabic labeling requirements.
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
Kuwait Pharmaceutical Registration Pathway
Market Overview
- Market profile: Kuwait is dominated by the public healthcare system and import channels. GCC and reference-market approvals from SFDA/EMA/FDA often have practical value.
- Regulatory maturity: Medium. MOH pharmaceutical affairs and drug control functions manage registration and import permits.
- Core decision: Confirm local agent, import permit, GCC/reference-market evidence, and Arabic labeling requirements.
Regulator
- Authority: Kuwait Ministry of Health (MOH)
- Relevant function: Pharmaceutical Affairs and Drug Control
- Official portal: https://www.moh.gov.kw
Registration Pathway
During the limited-time free period, sign in or register to view the complete pharmaceutical country report.